Innoviva Stock Analysis

Innoviva Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.57. Some equities with similar Price to Book (P/B) outperform the market in the long run. Innoviva has Price/Earnings To Growth (PEG) ratio of 0.24. The entity last dividend was issued on the 8th of September 2015. The firm had 1241:1000 split on the 3rd of June 2014. Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California. Innoviva operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. To learn more about Innoviva call the company at (650) 238-9600 or check out https://www.inva.com.

Innoviva Investment Alerts

Innoviva Upcoming and Recent Events

Innoviva Largest EPS Surprises

View All Earnings Estimates

Innoviva Environmental, Social, and Governance (ESG) Scores

Innoviva Thematic Classifications

Innoviva Stock Institutional Investors

Note, although Innoviva's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Innoviva Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.1 B.

Innoviva Profitablity

The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.49 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.49.

Management Efficiency

Innoviva has return on total asset (ROA) of 0.0888 % which means that it generated a profit of $0.0888 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0343 %, meaning that it created $0.0343 on every $100 dollars invested by stockholders. Innoviva's management efficiency ratios could be used to measure how well Innoviva manages its routine affairs as well as how well it operates its assets and liabilities. At present, Innoviva's Return On Tangible Assets are projected to increase slightly based on the last few years of reporting. The current year's Return On Capital Employed is expected to grow to 0.23, whereas Return On Equity is forecasted to decline to 0.03. At present, Innoviva's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 784.1 M, whereas Other Assets are forecasted to decline to about 131.6 M.

Technical Drivers

As of the 20th of March, Innoviva retains the Market Risk Adjusted Performance of (0.34), risk adjusted performance of (0.13), and Standard Deviation of 0.9457. Innoviva technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Innoviva Price Movement Analysis

Innoviva Insider Trading Activities

Innoviva Outstanding Bonds

Innoviva Predictive Daily Indicators

Innoviva Corporate Filings

Innoviva Forecast Models

Innoviva's time-series forecasting models are one of many Innoviva's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Innoviva's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Innoviva prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Innoviva shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Innoviva. By using and applying Innoviva Stock analysis, traders can create a robust methodology for identifying Innoviva entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Innoviva analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Innoviva analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Innoviva stock analysis indicators help investors evaluate how Innoviva stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Innoviva shares will generate the highest return on investment. By understating and applying Innoviva stock analysis, traders can identify Innoviva position entry and exit signals to maximize returns.

When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.